GenCure completes 80-litre stem cell production run

The run hugely scales up human mesenchymal stem cells production with two more runs planned to refine the process

picture of

Breaking News

Samsung BioLogics implements large scale N-1 perfusion

An Alternating Tangential Flow (ATF) device was used to reduce production time by 30% in a commercial production process

3P Biopharmaceuticals finds major new investor

The CDMO specialises in the process development and GMP manufacturing of biologics

PE firm acquires Aldevron

The CDMO from North Dakota has additional operations in Madison, Wisconsin, and Freiburg, Germany

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Halix begins viral vector production at new Dutch GMP facility

The new 6,700 sqm cGMP facility is in Leiden Bio Science Park just north of Rotterdam

University in Virginia starts first US pharma engineering PhD

Qualification will train students in manufacturing procedures focusing on areas of drug product development such as ...

Case Study: Phase I to commercial in 18 months

Druggability Technologies CEO, Gabor Heltovics, talks about using Quotient Sciences to progress and scale-up an ...

Mezzan Holdings acquires only pharma manufacturer in Kuwait

The 67% stake in the company was bought for around US$69 million

Brammer Bio in talks to build manufacturing site in Massachusetts

The US cell and gene therapy CDMO expects to employ around 300 people at the plant by 2021

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

Stainless steel products in contemporary bioprocessing

ASEPCO's Mark Embury on the shift from stainless steel to single-use systems in the pharmaceutical manufacturing sector

WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

Olon begins construction on new GMP API facility in Italy

The construction of the CDMO's new GMP facility is associated with a long-term strategic partnership with a large ...

Omeros chooses Lonza to transition from clinical to commercial supply

The new multi-year agreement secures a source of commercial quantities of narsoplimab for use following anticipated ...